Van Wyk Rosalind J, Serem June C, Oosthuizen Carel B, Semenya Dorothy, Serian Miruna, Lorenz Christian D, Mason A James, Bester Megan J, Gaspar Anabella R M
Department of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0002, South Africa.
Department of Anatomy, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa.
Biochemistry. 2025 Feb 18;64(4):841-859. doi: 10.1021/acs.biochem.4c00580. Epub 2025 Jan 28.
C-terminal amidation of antimicrobial peptides (AMPs) is a frequent minor modification used to improve antibacterial potency, commonly ascribed to increased positive charge, protection from proteases, and a stabilized secondary structure. Although the activity of AMPs is primarily associated with the ability to penetrate bacterial membranes, hitherto the effect of amidation on this interaction has not been understood in detail. Here, we show that amidation of the scorpion-derived membranolytic peptide AamAP1-Lys produces a potent analog with faster bactericidal activity, increased membrane permeabilization, and greater Gram-negative membrane penetration associated with greater conformational flexibility. AamAP1-lys-NH has improved antibiofilm activity against and , benefits from a two- to 3-fold selectivity improvement, and provides protection against infection in a burn wound model. Circular dichroism spectroscopy shows both peptides adopt α-helix conformations in the steady state. However, molecular dynamics (MD) simulations reveal that, during initial binding, AamAP1-Lys-NH has greater conformation heterogeneity, with substantial polyproline-II conformation detected alongside α-helix, and penetrates the bilayer more readily than AamAP1-Lys. AamAP1-Lys-NH induced membrane permeabilization of occurs only above a critical concentration with slow and weak permeabilization and slow killing occurring at its lower MIC but causes greater and faster permeabilization than AamAP1-Lys, and kills more rapidly, when applied at equal concentrations. Therefore, while the increased potency of AamAP1-Lys-NH is associated with slow bactericidal killing, amidation, and the conformational flexibility it induces, affords an improvement in the AMP pharmacodynamic profile and may need to be considered to achieve improved therapeutic performance.
抗菌肽(AMPs)的C末端酰胺化是一种常见的微小修饰,用于提高抗菌效力,通常归因于正电荷增加、抗蛋白酶作用以及二级结构稳定。尽管AMPs的活性主要与穿透细菌膜的能力有关,但迄今为止,酰胺化对这种相互作用的影响尚未得到详细了解。在此,我们表明,蝎源膜溶解肽AamAP1-Lys的酰胺化产生了一种强效类似物,具有更快的杀菌活性、增强的膜通透性以及与更大构象灵活性相关的更强革兰氏阴性膜穿透能力。AamAP1-lys-NH对金黄色葡萄球菌和大肠杆菌具有改善的抗生物膜活性,受益于2至3倍的选择性提高,并在烧伤伤口模型中提供针对铜绿假单胞菌感染的保护。圆二色光谱显示两种肽在稳态下均采用α-螺旋构象。然而,分子动力学(MD)模拟表明,在初始结合过程中,AamAP1-Lys-NH具有更大的构象异质性,除了α-螺旋外还检测到大量多聚脯氨酸-II构象,并且比AamAP1-Lys更容易穿透双层膜。AamAP1-Lys-NH诱导的膜通透性仅在高于临界浓度时发生,通透性缓慢且微弱,在其较低的最低抑菌浓度下发生缓慢杀伤,但在等浓度应用时比AamAP1-Lys导致更大、更快的通透性,并且杀伤更快。因此,虽然AamAP1-Lys-NH效力的提高与缓慢的杀菌作用有关,但酰胺化及其诱导的构象灵活性改善了AMP的药效学特征,可能需要考虑以实现更好的治疗效果。